Doctor profile · Federal record
Dr. Matthew Davids, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Boston, MA
- NPI 1659541522
- Accepts Medicare
- MIPS 83.1 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
450 Brookline Ave
Boston, MA 022155418
(617) 632-3000
fax (617) 632-5822
Credentials & registration
- NPI registered
- March 2008 — 18 yrs on file
- Profile last updated
- April 12, 2011
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Massachusetts #234844
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659541522. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
299
Distinct HCPCS
3
Medicare allowed
$35,953
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 219 | 178 | $105 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 61 | 43 | $154 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 19 | 19 | $194 |
In context: peer comparison
Among 64 peers in this city , average services per provider: 129. This provider delivers 2.3× the peer median.Open Payments
Industry payments received
All-time total
$101,162
Transactions
65
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 18 | $25,796.92 | |
| BeiGene Switzerland GmbH | 6 | $24,540.17 | |
| AstraZeneca Pharmaceuticals LP | 17 | $21,394.10 | |
| Eli Lilly and Company | 3 | $8,550.00 | |
| AstraZeneca UK Limited | 6 | $6,246.92 | |
| Genentech USA, Inc. | 2 | $3,800.00 | |
| Lilly USA, LLC | 1 | $3,150.00 | |
| Genmab U.S., Inc. | 3 | $2,735.02 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $2,160.20 | |
| BeiGene USA, Inc. | 4 | $2,118.55 | |
| BeiGene, Ltd. | 1 | $340.00 | |
| Genentech, Inc. | 1 | $330.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
62
Patients
0
Total drug cost
$951,779
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Venclexta (Venetoclax) | Brand | 23 | 0 | $341,056 |
| Imbruvica (Ibrutinib) | Brand | 22 | 0 | $338,612 |
| Calquence (Acalabrutinib Maleate) | Brand | 17 | 0 | $272,111 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Davids's medical specialty?
Dr. Matthew Davids practices Hematology & Oncology Physician in Boston, MA.
Where does Dr. Matthew Davids practice?
Dr. Matthew Davids practices at 450 Brookline Ave, Boston, MA 022155418. Office phone: 6176323000.
What is Dr. Matthew Davids's NPI?
Dr. Matthew Davids's National Provider Identifier (NPI) is 1659541522, issued by NPPES.
Does Dr. Matthew Davids accept Medicare assignment?
Yes. Dr. Matthew Davids accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Davids commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.